| SCHEDULE OF REVENUES, OPERATING EXPENSES AND OPERATING INCOME (LOSS) BY REPORTABLE SEGMENT |
SCHEDULE OF REVENUES, OPERATING EXPENSES AND OPERATING INCOME (LOSS) BY REPORTABLE SEGMENT
| | |
| | |
| | |
| |
| | |
Six Months Ended June 30, 2026 | |
| | |
($ in thousands) | |
| | |
Healthcare IT | | |
Medical
Practice
Management | | |
Total | |
| Net revenue | |
$ | 55,698 | | |
$ | 7,452 | (a) | |
$ | 63,150 | |
| Operating expenses: | |
| | | |
| | | |
| | |
| Direct operating costs | |
| 28,259 | | |
| 6,048 | | |
| 34,307 | |
| Selling and marketing | |
| 2,704 | | |
| 10 | | |
| 2,714 | |
| General and administrative | |
| 5,223 | | |
| 1,360 | | |
| 6,583 | |
| Research and development | |
| 4,610 | | |
| - | | |
| 4,610 | |
| Change in contingent consideration | |
| 23 | | |
| - | | |
| 23 | |
| Depreciation and amortization | |
| 7,603 | | |
| 165 | | |
| 7,768 | |
| Restructuring costs | |
| | | |
| | | |
| | |
| Total operating expenses | |
| 48,422 | | |
| 7,583 | | |
| 56,005 | |
| Segment operating income (loss) | |
$ | 7,276 | | |
$ | (131 | ) | |
| 7,145 | |
| | |
| | | |
| | | |
| | |
| Reconciliation of profit or loss (segment profit/loss): | |
| | | |
| | | |
| | |
| Unallocated corporate expenses | |
| | | |
| | | |
| (4,283 | ) |
| Net interest expense | |
| | | |
| | | |
| (790 | ) |
| Other income | |
| | | |
| | | |
| 126 | |
| Income before income taxes | |
| | | |
| | | |
$ | |
| | |
| | |
| | |
| |
| | |
Three Months Ended June 30, 2026 | |
| | |
($ in thousands) | |
| | |
Healthcare IT | | |
Medical
Practice
Management | | |
Total | |
| | |
| | |
| | |
| |
| Net revenue | |
$ | 28,194 | | |
$ | 3,686 | (a) | |
$ | 31,880 | |
| Operating expenses: | |
| | | |
| | | |
| | |
| Direct operating costs | |
| 14,436 | | |
| 3,021 | | |
| 17,457 | |
| Selling and marketing | |
| 1,298 | | |
| 2 | | |
| 1,300 | |
| General and administrative | |
| 2,550 | | |
| 717 | | |
| 3,267 | |
| Research and development | |
| 2,194 | | |
| - | | |
| 2,194 | |
| Change in contingent consideration | |
| (34 | ) | |
| - | | |
| (34 | ) |
| Depreciation and amortization | |
| 3,648 | | |
| 83 | | |
| 3,731 | |
| Total operating expenses | |
| 24,092 | | |
| 3,823 | | |
| 27,915 | |
| Segment operating income (loss) | |
$ | 4,102 | | |
$ | (137 | ) | |
| 3,965 | |
| | |
| | | |
| | | |
| | |
| Reconciliation of profit or loss (segment profit/loss) | |
| | | |
| | | |
| | |
| Unallocated corporate expenses | |
| | | |
| | | |
| (2,103 | ) |
| Net interest expense | |
| | | |
| | | |
| (742 | ) |
| Other income | |
| | | |
| | | |
| 104 | |
| Income before income taxes | |
| | | |
| | | |
$ | |
| | |
| | |
| | |
| |
| | |
Six Months Ended June 30, 2025 | |
| | |
($ in thousands) | |
| | |
Healthcare IT | | |
Medical
Practice
Management | | |
Total | |
| Net revenue | |
$ | 48,719 | | |
$ | 6,290 | (a) | |
$ | 55,009 | |
| Operating expenses: | |
| | | |
| | | |
| | |
| Direct operating costs | |
| 24,666 | | |
| 5,278 | | |
| 29,944 | |
| Selling and marketing | |
| 2,234 | | |
| 15 | | |
| 2,249 | |
| General and administrative | |
| 4,455 | | |
| 1,211 | | |
| 5,666 | |
| Research and development | |
| 2,255 | | |
| - | | |
| 2,255 | |
| Depreciation and amortization | |
| 6,555 | | |
| 164 | | |
| 6,719 | |
| Restructuring costs | |
| 137 | | |
| - | | |
| 137 | |
| Total operating expenses | |
| 40,302 | | |
| 6,668 | | |
| 46,970 | |
| Segment operating income (loss) | |
$ | 8,417 | | |
$ | (378 | ) | |
| 8,039 | |
| | |
| | | |
| | | |
| | |
| Reconciliation of profit or loss (segment profit/loss): | |
| | | |
| | | |
| | |
| Unallocated corporate expenses | |
| | | |
| | | |
| (3,024 | ) |
| Net interest expense | |
| | | |
| | | |
| (33 | ) |
| Other expense | |
| | | |
| | | |
| (49 | ) |
| Income before income taxes | |
| | | |
| | | |
$ | |
| | |
| | |
| | |
| |
| | |
Three Months Ended June 30, 2025 | |
| | |
($ in thousands) | |
| | |
Healthcare IT | | |
Medical
Practice
Management | | |
Total | |
| Net revenue | |
$ | 24,077 | | |
$ | 3,300 | (a) | |
$ | 27,377 | |
| Operating expenses: | |
| | | |
| | | |
| | |
| Direct operating costs | |
| 11,763 | | |
| 2,717 | | |
| 14,480 | |
| Selling and marketing | |
| 1,110 | | |
| 8 | | |
| 1,118 | |
| General and administrative | |
| 2,343 | | |
| 569 | | |
| 2,912 | |
| Research and development | |
| 1,020 | | |
| - | | |
| 1,020 | |
| Depreciation and amortization | |
| 3,300 | | |
| 82 | | |
| 3,382 | |
| Restructuring costs | |
| 23 | | |
| - | | |
| 23 | |
| Total operating expenses | |
| 19,559 | | |
| 3,376 | | |
| 22,935 | |
| Segment operating income (loss) | |
$ | 4,518 | | |
$ | (76 | ) | |
| 4,442 | |
| | |
| | | |
| | | |
| | |
| Reconciliation of profit or loss (segment profit/loss) | |
| | | |
| | | |
| | |
| Unallocated corporate expenses | |
| | | |
| | | |
| (1,446 | ) |
| Net interest expense | |
| | | |
| | | |
| (17 | ) |
| Other expense | |
| | | |
| | | |
| (35 | ) |
| Income before income taxes | |
| | | |
| | | |
$ | |
| (a) | This revenue represents
fees based on our actual costs plus a percentage of the operating profit. |
|